CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
28.67
+0.65 (2.32%)
Dec 20, 2024, 4:00 PM EST - Market closed
CG Oncology Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 1,939 | - | - | - |
| Enterprise Value | 1,399 | - | - | - |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.13 | 0.38 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | - |
| Quick Ratio | 34.60 | 13.17 | 9.32 | 8.97 |
| Current Ratio | 35.32 | 13.62 | 9.54 | 9.78 |
| Return on Equity (ROE) | -19.76% | -31.36% | -42.85% | - |
| Return on Assets (ROA) | -15.69% | -19.97% | -21.34% | - |
| Return on Capital (ROIC) | -16.27% | -21.24% | -22.42% | - |
| Buyback Yield / Dilution | -1143.67% | -15.77% | -2.47% | - |
| Total Shareholder Return | -1143.67% | -15.77% | -2.47% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.